2 results
Approved WMORecruiting
To find a simple test to explain non-responsiveness to sumatriptan in a proportion of patients with migraine.
Approved WMORecruiting
Primary objective: To evaluate the comparative long-term safety of TAK-503 treatment (formerly known as SPD503) in children and adolescentsaged 6 to 17 years diagnosed with ADHD for whom stimulants are not suitable, not tolerated, or shown to…